You have reached the server that hosted the tranSMART, OwnCloud and WebProtégé applications for the European Medical Information Framework (EMIF) project. To get access to the platform, please contact Isabelle Bos (isabelle.bos@maastrichtuniversity.nl) or Stephanie Vos (s.vos@maastrichtuniversity.nl) for questions.
If you are already a user, you can recover the access.
"With multiple clinical trials in dementia failing over the past years, attention has recently shifted to subjects with Alzheimer’s disease (AD) who have not reached the stage of dementia yet (i.e., ‘pre-dementia’). Since these subjects have limited brain damage and are suggested to be more likely responsive to treatment than subjects with full-blown dementia, they are an important target group for future treatment studies."
Learn more